Artificial Intelligence in Cancer Diagnostics Market Size Worth USD 2,174.26 Million by 2034 | CAGR: 25.9%

The artificial intelligence (AI) in cancer diagnostics market size is expected to reach USD 2,174.26 million by 2034, according to a new study by Polaris Market Research. The report “Artificial Intelligence in Cancer Diagnostics Market Size, Share, Trends, Industry Analysis Report: By Application (Screening & Diagnosis, Tumor Identification, Surveillance, and Treatment), Cancer Type, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The artificial intelligence in cancer diagnostics market involves the application of AI technologies, including machine learning and deep learning, to enhance the accuracy, efficiency, and speed of cancer detection and diagnosis. AI-powered solutions analyze medical imaging, pathology slides, and genomic data to assist healthcare professionals in identifying cancerous cells and predicting disease progression. The market is experiencing significant growth due to the increasing prevalence of cancer, rising demand for early detection, and advancements in AI-driven imaging and diagnostic tools. Growing adoption of AI in personalized medicine, increasing regulatory approvals, and expanding cloud-based AI solutions are further driving market expansion. The artificial intelligence in cancer diagnostics market opportunities exist in developing AI models for early-stage cancer detection, integrating AI with multi-omics data, and expanding accessibility in emerging markets. As investments in AI-driven healthcare solutions continue to rise, the market is expected to evolve with enhanced capabilities, improved clinical workflows, and greater integration into routine diagnostics.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/artificial-intelligence-in-cancer-diagnostics-market/request-for-sample

Artificial Intelligence (AI) in Cancer Diagnostics Market Report Highlights

• The screening & diagnosis segment, based on application, held the largest share of the artificial intelligence in cancer diagnostics market revenue in 2024 due to the widespread adoption of AI-driven imaging solutions for early cancer detection. The tumor identification segment is witnessing the fastest growth as AI models improve accuracy in distinguishing malignant and benign tumors.
• By cancer type, the breast cancer segment accounted for the largest market share in 2024 due to high global incidence rates and significant AI advancements in mammography. Lung cancer is the fastest-growing segment, driven by increasing demand for AI-powered CT scan analysis and early-stage detection solutions.
• North America led the artificial intelligence in cancer diagnostics market share in 2024 due to strong healthcare infrastructure, high AI adoption, and supportive regulatory policies. Asia Pacific is the fastest-growing region, driven by increasing healthcare digitization, rising cancer prevalence, and growing investments in AI-based diagnostics.
• Several companies in the market are actively contributing to advancements in early detection and treatment. Microsoft Corporation, IBM Corporation, Siemens Healthineers, GE Healthcare, and Tempus Labs, Inc. are a few notable entities. These organizations are at the forefront of integrating AI into healthcare to enhance diagnostic accuracy and patient outcomes.

Polaris Market Research has segmented the artificial intelligence (AI) in cancer diagnostics market report on the basis of application, cancer type, end use, and region:

By Application Outlook (Revenue – USD Million, 2020–2034)

• Screening & Diagnosis
• Tumor Identification
• Surveillance
• Treatment

By Cancer Type Outlook (Revenue – USD Million, 2020–2034)

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Cervical Cancer
• Others

By End Use Outlook (Revenue – USD Million, 2020–2034)

• Hospitals
• Diagnostic Centers
• Medical Research Institute
• Contract Research Organization
• Other

By Regional Outlook (Revenue – USD Million, 2020–2034)

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Artificial Intelligence in Cancer Diagnostics Market Report Scope